Home  >  TopNews
Msc_Apr22 Advertisement
6Sugar_Free_Sweetener.gif
you can get e-magazine links on WhatsApp. Click here
Corporate + Font Resize -

Pharma industry in top gear to accelerate its pace to take in qualified and trained workforce

Nandita Vijay, Bengaluru
Wednesday, December 22, 2021, 08:00 Hrs  [IST]

Pharma industry is in top gear to take in qualified and trained workforce. This is because to keep pace of the Indian pharma industry growth there is need for the right talent to support research, manufacture and marketing.

When the world is looking at India for medicines, be it vaccines, finished dosage forms, active pharmaceutical ingredients, clinical research and pharmacovigilance to name a few, it is the high quality of human resources that sets the pace to grab global projects. The access for the world to efficacious, safe and affordable medicines are an outcome of Indian pharma’s efficient workforce, noted Rachu Babu, head operation excellence, Bluefish Pharmaceuticals, Bengaluru, a Swedish multinational company.

Babu who was speaking at the recently concluded event on Pharmacy education, organized by Karnataka Registered Pharmacists Association and the Karnataka Drugs and Pharmaceutical Manufacturers Association, said that the pharma industry has consistently been on the growth path and the qualified talent pool are accelerating the pace of developments in the manufacturing sector.

Stating that the pharma industry is the third largest with US$ 5 trillion in public market value after banking- insurance, he said this was a great domain for the pharmacy graduate and post graduates aspiring in research in biotechnology and pharmaceutical sciences. Oncology, being one of the largest growing therapy areas, there is need for inventions and innovation options to manage this. There are already several large Indian pharma companies in this space supplying medicines globally and to the stringent regulated markets.

He also added that India supplies about 60 per cent of vaccine requirement globally. With the corona virus disease (Covid-19) having changed the vaccine landscape, it precipitates an inherent need for resources and qualified talent.

Low cost biosimilars are beginning to be accepted in the US and other parts of the developed world. As healthcare insurance is a substantial stakeholder in most developed countries, there is now an encouragement to choose biosimilars and generics.

Diseases like Alzheimer’s, oncology etc. are bringing about novel molecules and formulations to the market. This is creating employment opportunities in pharmacovigilance, clinical trials and post marketing surveillance, which is also an area for start-ups and new age entrepreneurs to pursue, he said.

Yet another area of choice is regulatory affairs. The regulatory norms are constantly evolving in an age of technology and people interface. This will see in the coming years qualified pharmacy graduates and post graduates chip in their acumen for supporting and managing policy changes and compliance to regulation.

One should also realize that Indian pharma has a long way to go with the prevailing global opportunities. Indian pharma is contributing a mere 2 per cent of India’s GDP with a domestic market of US$ 41 billion in 2021. There are more possibilities to explore in therapy, medical devices and allied areas, stated Babu.

There is considerable foreign direct investment (FDI) and here human resource is the key to unlock the value of potential investors. Avenues in e-pharmacy which is still in nascent stage, clinical research and digital technology driven businesses focusing on life sciences are here to stay.

There are openings in academia, industry 4.0 manufacturing, regulatory enforcement wings, marketing intelligence, supply chain, tech-transfers & scale-up, bio statistician and Intellectual Property related functions. No doubt pharma industry is in a top gear and is looking for qualified-trained workforce, stated Babu.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |